Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive IDH1 mutant gliomas.
暂无分享，去创建一个
F. Yamasaki | K. Sugiyama | Y. Muragaki | Y. Arakawa | N. Shinojima | R. Nishikawa | T. Wakabayashi | Kazumi Ito | R. Saito | T. Kumabe | Y. Miyakita | Y. Narita | A. Natsume | N. Hata | Y. Mineharu | Masaya Tachibana | Y. Kakurai | Soichiro Nishijima | H. Tsubouchi